11th MASH Drug Development Summit

The 11th MASH Drug Development Summit is dedicated to Non-Alcoholic Steatohepatitis challenges from drug discovery to late stage clinical development.

Key Topics

• Validation of non-invasive biomarker approaches and technologies to more robustly diagnose and track disease progression
• How to optimize recapitulation of human NASH in vivo and effectively translate into the clinic
• Clinical primary and secondary endpoints and road-map for regulatory path to approval
• Ways to improve drug efficacy in both early and late stage NASH by identifying and validating novel targets and drug mechanisms of action
• Join your peers in Cambridge, MA, to overcome the challenges that are preventing you from accelerating the development of your NASH candidate

Who should Attend

Drug developers.